Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Voorbach

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Molecular Imaging and Biology|October 24, 2015
Image quality of Zr-89 PET imaging in the Siemens microPET Focus 220 preclinical scannerTyler J Bradshaw, Martin J Voorbach, David R Reuter, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2019
Utilization of <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In VivoSarah R Mudd, Martin J Voorbach, Dong Cheng, et al.
Pain|August 27, 2013
Multimodal assessment of nervous and immune system responses following sciatic nerve injuryLoren Lasko, Xin Huang, Martin J Voorbach, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 11, 2013
Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2Shundong Ji, Yang Zhou, Martin J Voorbach, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2012
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft modelSarah R Mudd, Martin J Voorbach, David R Reuter, et al.
Analytical Biochemistry|April 29, 2004
Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platformsJie Qian, Martin J Voorbach, Jeffrey R Huth, et al.
European Journal of Pharmacology|April 14, 2010
In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemiaAndrew J King, Jason A Segreti, Kelly J Larson, et al.
Journal of Biomolecular Screening|September 16, 2006
An ultraefficient affinity-based high-throughout screening process: application to bacterial cell wall biosynthesis enzyme MurFKenneth M Comess, Mark E Schurdak, Martin J Voorbach, et al.
Molecular Imaging and Biology|December 15, 2011
Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft modelSarah R Mudd, Kimberley D Holich, Martin J Voorbach, et al.
Journal of Biomolecular Screening|September 8, 2006
Kinase drug discovery by affinity selection/mass spectrometry (ASMS): application to DNA damage checkpoint kinase Chk1Kenneth M Comess, Jonathan D Trumbull, Chang Park, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecular Imaging and Biology|October 24, 2015
Image quality of Zr-89 PET imaging in the Siemens microPET Focus 220 preclinical scannerTyler J Bradshaw, Martin J Voorbach, David R Reuter, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2019
Utilization of <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In VivoSarah R Mudd, Martin J Voorbach, Dong Cheng, et al.
Pain|August 27, 2013
Multimodal assessment of nervous and immune system responses following sciatic nerve injuryLoren Lasko, Xin Huang, Martin J Voorbach, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 11, 2013
Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2Shundong Ji, Yang Zhou, Martin J Voorbach, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2012
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft modelSarah R Mudd, Martin J Voorbach, David R Reuter, et al.
Analytical Biochemistry|April 29, 2004
Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platformsJie Qian, Martin J Voorbach, Jeffrey R Huth, et al.
European Journal of Pharmacology|April 14, 2010
In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemiaAndrew J King, Jason A Segreti, Kelly J Larson, et al.
Journal of Biomolecular Screening|September 16, 2006
An ultraefficient affinity-based high-throughout screening process: application to bacterial cell wall biosynthesis enzyme MurFKenneth M Comess, Mark E Schurdak, Martin J Voorbach, et al.
Molecular Imaging and Biology|December 15, 2011
Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft modelSarah R Mudd, Kimberley D Holich, Martin J Voorbach, et al.
Journal of Biomolecular Screening|September 8, 2006
Kinase drug discovery by affinity selection/mass spectrometry (ASMS): application to DNA damage checkpoint kinase Chk1Kenneth M Comess, Jonathan D Trumbull, Chang Park, et al.
Pageof 2